MAPT and Cognitive impairment: Interestingly, a recent 99 m Tc-TRODAT-1 imaging study found that, when compared with normal adults, PD patients with cognitive impairment have higher plasma levels of the biomarkers α-synuclein and T-tau, and lower levels of amyloid-beta40 (P < 0.05) [4].